Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.
Weng G, Huang J, He X, Xue T, Yang L, Zhang Y, Yu G, Sun Z, Lin D, Deng L, Liang X, Xiao J, Zhang H, Guo Z, Jin H, Liu Q, Du X. Weng G, et al. Among authors: liang x. Ann Hematol. 2023 Dec;102(12):3369-3381. doi: 10.1007/s00277-023-05452-7. Epub 2023 Sep 18. Ann Hematol. 2023. PMID: 37723307
Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.
Jiang X, Xu L, Zhang Y, Huang F, Liu D, Sun J, Song C, Liang X, Fan Z, Zhou H, Dai M, Liu C, Jiang Q, Xu N, Xuan L, Wu M, Huang X, Liu Q. Jiang X, et al. Among authors: liang x. Oncoimmunology. 2016 Mar 10;5(5):e1139274. doi: 10.1080/2162402X.2016.1139274. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467959 Free PMC article.
Retrospective cohort study comparing the outcomes of intravenous busulfan vs. total-body irradiation after single cord blood transplantation.
Tang B, Zhu X, Zheng C, Liu H, Hao S, Huang D, Lin D, Li N, Gao S, Liang X, Li J, Huang L, Geng L, Ding K, Wang X, Yao W, Song K, Zhang X, Wan X, Zhang L, Tong J, Sun G, Wei Z, Liu X, Wu Y, Sun Z. Tang B, et al. Among authors: liang x. Bone Marrow Transplant. 2019 Oct;54(10):1614-1624. doi: 10.1038/s41409-019-0441-4. Epub 2019 Feb 25. Bone Marrow Transplant. 2019. PMID: 30804484
Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation.
Xuan L, Wang Y, Chen J, Jiang E, Gao L, Wu B, Deng L, Liang X, Huang F, Fan Z, Tang X, Sun J, Zhang X, Han M, Wu D, Huang X, Liu Q. Xuan L, et al. Among authors: liang x. Biol Blood Marrow Transplant. 2019 Aug;25(8):1674-1681. doi: 10.1016/j.bbmt.2019.04.018. Epub 2019 Apr 19. Biol Blood Marrow Transplant. 2019. PMID: 31009704 Free article. Clinical Trial.
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.
Xuan L, Wang Y, Huang F, Fan Z, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Wang Z, Jiang L, Yu C, Zhou X, Lin R, Chen Y, Tu S, Huang X, Liu Q. Xuan L, et al. Among authors: liang x. Lancet Oncol. 2020 Sep;21(9):1201-1212. doi: 10.1016/S1470-2045(20)30455-1. Epub 2020 Aug 10. Lancet Oncol. 2020. PMID: 32791048 Clinical Trial.
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
Xu X, Fan Z, Wang Y, Huang F, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Chen Y, Tu S, Huang X, Liu Q, Xuan L. Xu X, et al. Among authors: liang x. BMC Med. 2022 Sep 2;20(1):282. doi: 10.1186/s12916-022-02479-x. BMC Med. 2022. PMID: 36050712 Free PMC article. Clinical Trial.
15,425 results
You have reached the last available page of results. Please see the User Guide for more information.